In the United States, annual vaccination against seasonal influenza is recommended for all persons aged 656 months. Each season since 2004-05, CDC has estimated the effectiveness of seasonal influenza vaccine in preventing medically attended acute respiratory illness (ARI) associated with laboratory-confirmed influenza. This season, early estimates of influenza vaccine effectiveness are possible because of widespread, early circulation of influenza viruses. By January 3, 2015, 46 states were experiencing widespread flu activity, with predominance of influenza A (H3N2) viruses. This report presents an initial estimate of seasonal influenza vaccine effectiveness at preventing laboratory-confirmed influenza virus infection associated with med...
Background: The effectiveness of currently licensed vaccines against influenza has not been clearly ...
International audienceThe ongoing influenza epidemic is characterized by intense activity with most ...
Influenza is an acute viral respiratory disease that affects persons of all ages and is associated w...
In the United States, annual vaccination against seasonal influenza is recommended for all persons a...
Influenza viruses typically circulate in the United States annually, most commonly from the late fal...
BACKGROUND: Evidence establishing effectiveness of influenza vaccination for prevention of severe il...
BACKGROUND: The 2014-2015 influenza season was severe, with circulating influenza A (H3N2) viruses t...
Background. During the 2012–2013 influenza season, there was cocirculation of influenza A(H3N2) and ...
AbstractBackgroundInfluenza vaccines are now widely used to reduce the burden of annual epidemics of...
Background. Influenza vaccines may be reformulated annually because of antigenic drift in influenza ...
Background: Influenza has had a large impact in the US, with an estimated 30.9 million cases and 14....
BACKGROUND: The severity of the 2017-2018 influenza season in the United States was high, with influ...
BACKGROUND: The effectiveness of currently licensed vaccines against influenza has not been clearly ...
Background: The effectiveness of currently licensed vaccines against influenza has not been clearly ...
International audienceThe ongoing influenza epidemic is characterized by intense activity with most ...
Influenza is an acute viral respiratory disease that affects persons of all ages and is associated w...
In the United States, annual vaccination against seasonal influenza is recommended for all persons a...
Influenza viruses typically circulate in the United States annually, most commonly from the late fal...
BACKGROUND: Evidence establishing effectiveness of influenza vaccination for prevention of severe il...
BACKGROUND: The 2014-2015 influenza season was severe, with circulating influenza A (H3N2) viruses t...
Background. During the 2012–2013 influenza season, there was cocirculation of influenza A(H3N2) and ...
AbstractBackgroundInfluenza vaccines are now widely used to reduce the burden of annual epidemics of...
Background. Influenza vaccines may be reformulated annually because of antigenic drift in influenza ...
Background: Influenza has had a large impact in the US, with an estimated 30.9 million cases and 14....
BACKGROUND: The severity of the 2017-2018 influenza season in the United States was high, with influ...
BACKGROUND: The effectiveness of currently licensed vaccines against influenza has not been clearly ...
Background: The effectiveness of currently licensed vaccines against influenza has not been clearly ...
International audienceThe ongoing influenza epidemic is characterized by intense activity with most ...
Influenza is an acute viral respiratory disease that affects persons of all ages and is associated w...